Case number 1:18-cv-00549
Shire Development LLC et al v. Impax Laboratories LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 17 | Motion for Leave to Appear Pro Hac Vice (1) |
| Jul 8, 2020 | 9 | Motion for Leave to Appear Pro Hac Vice (1) |
| Oct 10, 2019 | 22 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,913,768 B2; 8,846,100 B2; 9,173,857 B2. (Attachments: # (1) Consent Judgment)(nms) |
| Oct 10, 2019 | 22 | Consent Judgment (4) |
| Oct 10, 2019 | 22 | Patent/Trademark Report to Commissioner (1) |
| Oct 10, 2019 | N/A | Remark (0) Docket Text: Remark: The case has been closed per the entry of D.I. 202 in Lead Civil Action 17-1696-RGA. (nms) |
| Jun 27, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 6/28/2018, is now CANCELED, and the case is closed for administrative purposes (see D.I. [20]). Ordered by Judge Richard G. Andrews on 6/27/2018. (nms) |
| Jun 27, 2018 | 20 | Order (3) Docket Text: SO ORDERED Granting (31 in 17-cv-1696-RGA, 19 in 18-cv-549-RGA) Stipulated Consolidation Order. Signed by Judge Richard G. Andrews on 6/27/2018. Associated Cases: 1:17-cv-01696-RGA, 1:18-cv-00549-RGA(nms) |
| Jun 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney C. Kyle Musgrove for Impax Laboratories LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Jun 26, 2018 | 18 | Main Document (9) Docket Text: PROPOSED Scheduling Order, by Shire Development LLC, Shire LLC, Shire US Inc.. (Attachments: # (1) letter)(Jacobs, Karen) Modified on 6/27/2018 (nms). |
| Jun 26, 2018 | 19 | Proposed Order (3) Docket Text: Stipulated Consolidation Order, by Shire Development LLC, Shire LLC, Shire US Inc.. (Jacobs, Karen) Modified on 6/27/2018 (nms). |
| Jun 26, 2018 | 18 | Cover letter (1) |
| Jun 26, 2018 | 18 | Proposed Order (9) |
| Jun 22, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney C. Kyle Musgrove and Scott A. Cunning, II, filed by Impax Laboratories LLC. Signed by Judge Richard G. Andrews on 6/22/2018. (nms) |
| Jun 21, 2018 | 17 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney C. Kyle Musgrove and Scott A. Cunning, II - filed by Impax Laboratories LLC. (Attachments: # (1) Certification of C. Kyle Musgrove, # (2) Certification of Scott A. Cunning, II)(Bilson, David) |
| Jun 21, 2018 | 17 | Certification of Scott A. Cunning, II (1) |
| Jun 21, 2018 | 17 | Certification of C. Kyle Musgrove (1) |
| Jun 4, 2018 | 16 | Disclosure Statement (2) Docket Text: Second Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals LLC for Impax Laboratories LLC filed by Impax Laboratories LLC. (Phillips, John) |
| Jun 4, 2018 | 15 | SO ORDERED (2) Docket Text: SO ORDERED, re [14] Stipulation and Order to Reflect Name Change and Update Caption. Signed by Judge Richard G. Andrews on 6/4/2018. (nms) |
| Jun 4, 2018 | 14 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Reflect Name Change and Update Caption by Impax Laboratories, Inc.. (Phillips, John) |
| May 30, 2018 | 13 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 6/28/2018, at 2:00 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 5/29/2018. (nms) |
| May 23, 2018 | 12 | Answer to Counterclaim (12) Docket Text: ANSWER to [7] Answer to Complaint, Counterclaim by Shire Development LLC, Shire LLC, Shire US Inc..(Jacobs, Karen) |
| May 15, 2018 | 11 | Disclosure Statement (1) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals, Inc. for Impax Laboratories, Inc. filed by Impax Laboratories, Inc.. (Bilson, David) |
| May 9, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| May 9, 2018 | N/A | SO ORDERED (0) |
| May 8, 2018 | 10 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Sandra Kuzmich, Nicholas F. Giove and Kevin J. Georgek of Haug Partners LLP - filed by Shire Development LLC, Shire LLC, Shire US Inc.. (Jacobs, Karen) |
| May 8, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| May 7, 2018 | 9 | Certification of Elizabeth M. Crompton (1) |
| May 7, 2018 | N/A | SO ORDERED (0) |
| May 7, 2018 | 9 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elizabeth M. Crompton - filed by Impax Laboratories, Inc.. (Attachments: # (1) Certification of Elizabeth M. Crompton)(Bilson, David) |
| May 2, 2018 | 8 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Impax Laboratories, Inc.. (Phillips, John) |
| May 2, 2018 | 7 | Answer to Complaint (24) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by Impax Laboratories, Inc..(Phillips, John) Modified on 5/2/2018 (nms). |
| Apr 18, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Apr 16, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Shire LLC, Shire Development LLC, Shire US Inc.. Impax Laboratories, Inc. served on 4/16/2018, answer due 5/7/2018. (Blumenfeld, Jack) |
| Apr 13, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Shire plc for Shire Development LLC, Shire LLC, Shire US Inc. filed by Shire Development LLC, Shire LLC, Shire US Inc. (nmfn) |
| Apr 13, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,913,768 B2; 8,846,100 B2; 9,173,857 B2. (nmfn) |
| Apr 13, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/6/2018. Date of Expiration of '768 Patent: 5/24/2023. Date of Expiration of '100 Patent: 8/24/2029. Date of Expiration of '857 Patent: 5/12/2026. Thirty Month Stay Deadline: 9/6/2020. (nmfn) |
| Apr 13, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Apr 13, 2018 | 1 | Civil Cover Sheet (1) |
| Apr 13, 2018 | 1 | Main Document (14) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Impax Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2360759.) - filed by Shire LLC, Shire Development LLC, Shire US Inc. (Attachments: # (1) Exhibits A-C, # (2) Civil Cover Sheet)(nmfn) |
| Apr 13, 2018 | 1 | Exhibits A-C (89) |
| Apr 13, 2018 | 1 | Complaint (14) |
| Apr 13, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Impax Laboratories, Inc. on 4/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
